# Sources — Higuchi Ichiyō

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 5, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. National Diet Library, Japan. “Portraits of Modern Japanese Historical Figures: HIGUCHI Ichiyo.” Supports her dates (May 2, 1872, to November 23, 1896), her birth in Tokyo, her study of poetry at Nakajima Utako’s Haginoya from 1886, the support of her family after her father’s death in 1889, her apprenticeship to Nakarai Tōsui from 1891, *Umoregi* (1892), the small shop selling household goods and cheap sweets in Shitaya, *Ōtsugomori* (1894), *Nigorie* (1895) and *Takekurabe* (1895), her diaries, and that she died in poverty of lung tuberculosis. https://www.ndl.go.jp/portrait/e/datas/315.html
2. Kotobank (Asahi Shimbun), entries for 樋口一葉 from 日本大百科全書(ニッポニカ) (Shogakukan), 世界大百科事典 (Heibonsha) and デジタル版 日本人名大辞典+Plus (Kodansha), in Japanese. Supports her birth on 明治5年3月25日（新暦5月2日） in official housing in the Tokyo prefectural office grounds in Uchisaiwai-chō; her given name なつ (Natsu), also written 夏子 (Natsuko); her father’s death in 1889; the shop in Shitaya Ryūsenji-chō from July 1893 to April 1894; the move to Hongō Maruyama-Fukuyama-chō (now Nishikata, Bunkyō) in May 1894; the “miraculous year” (奇蹟の一年) up to January 1896; the rapid decline of her health from the beginning of 1896; her death on 明治29年11月23日; and, in Nipponica, miliary tuberculosis (粟粒結核) as the cause. https://kotobank.jp/word/%E6%A8%8B%E5%8F%A3%E4%B8%80%E8%91%89-17510
3. Nippon.com. “Higuchi Ichiyō” (Shapers of Japanese History). Supports her birth as Higuchi Natsu on May 2, 1872, in what is now Chiyoda; her father’s death of illness in the summer of 1889, when she was 17, leaving debts from a failed business; the washing and needlework her mother and younger sister took on; the shop in a low-rent row house beside the Yoshiwara, closed after about ten months; “the miraculous 14 months” of work at the Bunkyō house; *Takekurabe*, *Nigorie* and *Jūsan’ya*; tuberculosis; her death on November 23, 1896, at 24; and her portrait on the 5,000-yen note since 2004. https://www.nippon.com/en/japan-topics/b07226/
4. Taito City Culture Foundation. “Ichiyo Memorial Museum.” Supports her support of her mother and sister after her father died when she was 17, her choice to earn her living as a novelist, the small general store in Ryūsenji, the use of her life there in *Takekurabe*, her death of tuberculosis at 24, her portrait on the 5,000-yen note, and the museum’s founding by Taito City in 1961. https://taitogeibun.net/english/ichiyo
5. Bank of Japan. “Bank of Japan Notes and Coins Currently Issued.” Supports the 5,000-yen note with her portrait and Ogata Kōrin’s irises on the back, first issued November 1, 2004, and the new 5,000-yen note first issued July 3, 2024. https://www.boj.or.jp/en/note_tfjgs/note/valid/issue.htm
6. National Diet Library, Japan. “Calendar History 2.” Supports that the 3rd day of the 12th month of Meiji 5 became January 1 of Meiji 6 (1873) when Japan adopted the Gregorian calendar. https://www.ndl.go.jp/koyomi/e/history/calendar.html
7. Bunkyō City. 「樋口一葉」 (文京ゆかりの文人), in Japanese. Supports her study at the Haginoya, her residence at Hongō Maruyama-Fukuyama-chō no. 4 (now Nishikata 1-17) from May 1894, her works *Ōtsugomori*, *Takekurabe*, *Nigorie* and *Jūsan’ya*, and her death at her Hongō home on November 23, 1896, at 24. https://www.city.bunkyo.lg.jp/b014/p003900.html
8. HISTMED Master Roster v3. Internal project source; not treated as independent corroboration.

## Clinical guidance

1. Nahid P, et al. Official ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. *Clin Infect Dis* 2016;63(7):e147-e195 (PMID 27516382): the six-month regimen, daily directly observed therapy, weight-based dosing, stopping ethambutol on susceptibility, pyridoxine, monthly clinical review, sputum at two months, and a seven-month continuation phase for cavitary disease with a positive two-month culture, with extension considered when either is present together with other factors such as low weight. The recommendations are taken from the guideline as summarized in its abstract and widely published tables; the full text was not re-read for this record. https://pubmed.ncbi.nlm.nih.gov/27516382/
2. Saukkonen JJ, et al. Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. *Am J Respir Crit Care Med* 2025;211(1):15-33 (PMID 40693952): the four-month rifapentine-moxifloxacin regimen as an option for pulmonary tuberculosis. Read through its PubMed abstract. https://pubmed.ncbi.nlm.nih.gov/40693952/
3. World Health Organization. WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment (2022): the four-month rifapentine regimen and the standard six-month regimen as an alternative; dose ranges by weight. https://www.who.int/publications/i/item/9789240048126
4. Lewinsohn DM, et al. Official ATS/IDSA/CDC Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children. *Clin Infect Dis* 2017 (PMID 28052967): three sputum specimens, nucleic acid amplification, culture and susceptibility testing. https://pubmed.ncbi.nlm.nih.gov/28052967/
5. Centers for Disease Control and Prevention. Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis, United States, 2022 (*MMWR*): eligibility at age 12 or older and body weight of at least 40 kg; not recommended under 40 kg or in pregnancy. https://www.cdc.gov/mmwr/volumes/71/wr/mm7108a1.htm
6. Saukkonen JJ, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy (2006; PMID 17021358). https://pubmed.ncbi.nlm.nih.gov/17021358/
7. National Tuberculosis Controllers Association and CDC. Guidelines for the investigation of contacts of persons with infectious tuberculosis (2005; PMID 16357823). https://pubmed.ncbi.nlm.nih.gov/16357823/
8. Ministry of Health, Labour and Welfare, Japan. 結核 (tuberculosis) notification criteria under Article 12 of the Infectious Diseases Control Law: a physician who diagnoses tuberculosis must notify the nearest public health center at once. The page displayed with garbled characters; the immediate-notification requirement was confirmed from the readable text and MHLW search results. https://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou11/01-02-02.html
9. Niigata Prefecture. 結核医療費の公費負担: under Article 37-2, 95 percent of outpatient tuberculosis treatment costs (mainly drugs, X-rays and bacteriology) are publicly funded, with 5 percent paid by the patient; under Article 37, patients admitted on a public health recommendation because they may infect others are treated in a tuberculosis ward largely without charge. https://www.pref.niigata.lg.jp/sec/kanyaku/1356823070494.html
10. White JV, et al. Academy of Nutrition and Dietetics and ASPEN consensus statement on adult malnutrition (2012; PMID 22535923). https://pubmed.ncbi.nlm.nih.gov/22535923/
11. Gupta K, et al. IDSA and ESCMID guidelines for acute uncomplicated cystitis and pyelonephritis in women (2010 update; PMID 21292654). https://pubmed.ncbi.nlm.nih.gov/21292654/
12. U.S. Preventive Services Task Force A and B recommendations and topic recommendations (depression 2023, anxiety 2023, cervical cancer 2018, unhealthy alcohol use 2018, intimate partner violence 2018, folic acid 2023, chlamydia and gonorrhea 2021, HIV 2019, hepatitis C 2020); CDC hepatitis B screening (2023; PMID 36893044), U.S. Selected Practice Recommendations for Contraceptive Use (2024; PMID 39106301), and the Adult Immunization Schedule by Age; Medicare Preventive Services reference (Aether Forge, 2026). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations

The CMID has no tuberculosis monograph, so the record relies on the specialty guidelines above.

## Editorial resolutions

- **Recent-death rule.** She died in 1896, so the rule does not apply. Claims are limited to what the fetched sources state. No claim concerns mental health or substance use.
- **Name (judgment call).** Japanese order puts the family name first: Higuchi is the family name and Ichiyō a pen name; her given name was Natsu, also written Natsuko. The record uses the name she is known by, with identity.name_parts given “Ichiyō”, family “Higuchi” and family_first true, as other family-name-first records do; the notes call her Ms. Higuchi. The macron in Ichiyō is kept throughout. The aliases “Higuchi Natsu” and “Higuchi Natsuko” appear in no other record. The National Diet Library English page labels “Natsu” a pen name; the Japanese encyclopedias give なつ as her real name (本名), which the record follows.
- **Birth date and calendar.** Japan used a lunisolar calendar until the end of Meiji 5, when the 3rd day of the 12th month became January 1, 1873 (National Diet Library). Her birth, Meiji 5, 3rd month, 25th day, is given by Nipponica as May 2 in the new calendar, which the National Diet Library and Nippon.com also give; the record uses the Gregorian date and notes the original. Her death in 1896 is in the Gregorian calendar.
- **Corrections to the brief.** The “about fourteen months” of major work is Nippon.com’s phrase (“the miraculous 14 months”); Nipponica speaks of “the miraculous year” ending in January 1896. Both are recorded in CLM-0008. The cause of death is tuberculosis in every source, but the National Diet Library gives lung tuberculosis and Nipponica miliary tuberculosis; CLM-0011 records both, and the modern pulmonary diagnosis is linked to the documented disease without choosing between them. The shop was in Shitaya Ryūsenji-chō beside the Yoshiwara from July 1893 to April 1894, about ten months.
- **Index age and dates.** The index visit on April 14, 2026 maps to April 14, 1896, when she was 23 and living in Hongō Maruyama-Fukuyama-chō, after her health began to decline early in 1896 and before her death on November 23, 1896. The synthetic date of birth is May 2, 2002 (shift 130 years). All visits, through October 20, 2026 (October 20, 1896), fall within her lifetime; she turns 24 between the third and fourth visits. The modern visits are a teaching episode, not a claim about her real care or condition on those dates.
- **Presenting problem.** Seven weeks of cough, fevers, night sweats and weight loss at intake is its own problem (R05.3, chronic cough), resolved at the results visit three days later when pulmonary tuberculosis (A15.0) is recorded. The intake documents show only what was known then. Malnutrition (E44.0) and low income (Z59.6) are recorded at intake.
- **Smear-negative, outpatient care (judgment call).** The record makes her smear-negative with a positive Xpert MTB/RIF Ultra result (“low”) and no cavity. In Japan, patients at risk of infecting others are admitted to a tuberculosis ward on the public health center’s recommendation; smear-negative patients are usually treated as outpatients with public funding of 95 percent of costs (Article 37-2). The record therefore keeps her at home with precautions and ends them after two weeks of treatment with clinical improvement, with the public health center’s agreement. A reviewer should confirm this reading of Japanese practice.
- **Regimen choice (judgment call).** The brief allowed either regimen. At 38.4 to 38.5 kg she is below the 40 kg the CDC 2022 interim guidance requires for the four-month rifapentine-moxifloxacin regimen, so the standard six-month regimen is used. Whether rifapentine is available in Japan was not confirmed from a fetched source and did not decide the choice. Doses are weight-based: isoniazid 200 mg, rifampin 450 mg, pyrazinamide 1000 mg and ethambutol 600 mg, with pyridoxine 50 mg. Ethambutol is stopped after five weeks when the isolate proves susceptible; the continuation phase is four months because there was no cavity.
- **Focused visits.** The four chronic-care follow-ups (results visit with the consultation, two weeks, the end of the intensive phase at eight weeks, and the end of treatment) are documented as focused visits on the ATS/CDC/IDSA 2016 guideline and its 2025 update, the WHO 2022 guideline, the ATS hepatotoxicity statement, the CDC contact-investigation guideline, and the Japanese notification and funding rules. Two deviations are recorded at the eight-week visit instead of invented results: the liver tests and the vision check due about four weeks into treatment were not done, because no visit was booked and the phone call that stopped ethambutol did not include them; no harm judging by normal liver tests and unchanged acuity at eight weeks; tests due between visits are now booked as laboratory visits, and future ethambutol courses with monthly vision checks. Liver tests in the continuation phase are for symptoms only, because the intensive-phase tests stayed normal and albumin recovered; this follows the ATS approach for patients without ongoing risk factors and is a judgment call.
- **Consultation.** The infectious diseases referral and the consultation by Hiroshi Abernathy-Okoye, MD (a fictional consultant), on the day of the results visit, are **S**. The consultant answers the six referral questions in line with what the record shows afterwards: Xpert confirms tuberculosis despite negative smears; the six-month regimen because she is under 40 kg; outpatient care with precautions for two weeks; liver tests at two weeks and monthly in the intensive phase and vision checks while on ethambutol (the month-one checks were missed, as recorded); ethambutol stopped on susceptibility and a four-month continuation phase; and a contact investigation by the public health center.
- **Real people.** Her mother and younger sister, her father, Nakajima Utako and Nakarai Tōsui appear only in documented history claims. The modern social history describes a household of three adults without naming anyone, and the contact investigation records no statement, decision or result for any household member: their results are said to belong to their own records. No relative is the health care agent; the agent is unnamed. The father’s death is recorded in family history as “cause not recorded in the cited source”.
- **Equity and culturally appropriate care.** The record treats poverty as a clinical problem: public funding is applied for on the day of diagnosis, a medical social worker arranges instalments, the dietitian’s plan uses affordable foods she already eats, and the writing plan protects her income. The fear of stigma among neighbors and editors is recorded as her concern, and the precautions are explained so that they end as soon as it is safe.
- **Sick visit.** Acute uncomplicated cystitis in the continuation phase, chosen because it teaches two tuberculosis lessons: rifampin colors urine and can make dipstick color pads unreliable, so microscopy and culture are used, and fluoroquinolones are avoided during tuberculosis treatment. Nitrofurantoin does not interact with isoniazid or rifampin. It implies no real diagnosis.
- **Preventive visit.** A periodic adult preventive visit at 24 (CPT 99395 with 99497 in plain text). Judgment calls: first cervical cytology at 24; chlamydia and gonorrhea screening not indicated because she is not sexually active; contraception counseling about the rifampin interaction; Tdap, hepatitis B (two doses) and catch-up HPV vaccination (doses 1 and 2 in the record, dose 3 due afterwards); influenza vaccine at the end-of-treatment visit; advance care planning limited to her own general preferences, with an unnamed agent.
- **Setting.** The modern frame is a clinic in Tokyo within Japan’s public health system. The record keeps the project’s conventions (the fictional facility name, a synthetic SSN, CPT codes in plain text, USPSTF and CDC preventive guidance) and adds the Japanese notification and funding rules.
- **Synthetic content.** All visits, laboratory values, vital signs, X-ray findings, bacteriology (smears, Xpert, culture, susceptibility), survey scores, medicines and doses, the cystitis, her height (148 cm) and weights, her diet, the household arrangements, the public funding and instalments, and the health care agent are synthetic. Qualitative results (smears, Xpert, cultures, susceptibility, HIV, hepatitis and pregnancy tests, urine microscopy and culture, cervical cytology) appear only in the note text.
- **Sources not used.** Robert Lyons Danly’s *In the Shade of Spring Leaves* (Yale University Press, 1981) was found only as catalogue records and was not read; no claim rests on it. Britannica returned an access error. A personal website’s statement that her symptoms began in the spring of 1896 with high fevers in July, and details of the physicians who examined her in 1896, were not confirmed from a reliable fetched source and are left out.
